BioXCell公司于1997年，成立于美国新罕布什尔州，具有超过25年单克隆抗体和重组蛋白的生产及定制经验。BioXCell通过大规模生产和亲和纯化抗体，可以提供50或100mg的大包装以及高达50g规格的抗体，所有抗体均具有高纯度、低内毒素、无防腐剂的特点，具有非常高的性价比，是做小鼠体内研究的不二之选，是体内研究抗体的金标准。目前BioXCell产品已有超过20000篇文献引用，尤其是肿瘤研究相关指标PD-1,PD-L1和CTLA-4抗体得到了广大研究者的广泛使用和好评。
为了支持中国用户的研究，回馈广大客户，BioXCell厂家联合欣博盛生物推出为期1个月的限时促销活动，一年仅此一次，请各位老师千万不要错过这次囤货的机会！
活动时间：2024年5月7日-2024年6月5日
活动代码：10pCH2024
活动内容：订购 BioXCell 目录规格的体内研究级别抗体（1mg, 5mg, 10mg, 25mg, 50mg, 100mg）或抗体稀释液即可享受 额外10%折扣
活动说明：
1、BioXCell 中国库存中心的现货产品也可参加本活动；
2、本活动不与其他促销活动和特殊折扣并行；
3、本活动最终解释权归欣博盛生物所有。
▶ BioXCell的InVivoMab和InVivoPlus产品线之间如何选择？
| InvivoMab | InvivoPlus | |
| 是否经过结合验证(immunoblot，FC或ELISA验证) | No | Yes |
| 是否经过鼠科病原体检测(采用超灵敏实时荧光定量PCR检测) | No | Yes |
| 是否经验证蛋白聚集筛选(由动态光散射确定) | No | Yes |
| 内毒素含量 (LAL测定) | ＜2EU/mg | ＜1EU/mg |
| 纯度测定(SDS-PAGE) | >95% | >95% |
| 是否不含防腐剂、稳定剂和载体蛋白 | Yes | Yes |
| 是否适用于体内研究 | Yes | Yes |
| 产品货号 | BE-开头 | BP-开头 |
这些指标的抗体最畅销！
▶ 肿瘤研究抗体
| 抗原 | 应用 | InVivoMab 目录号 |
InVivoPlus 目录号 |
| PD-1 (CD279) | in vivo blocking of PD-1/PD-L signaling, WB | BE0146 | BP0146 |
| in vivo blocking of PD-1/PD-L signaling, in vitro PD-1 neutralization | BE0033-2 | BP0033-2 | |
| PD-L1(B7-H1) | in vivo PD-L1 blockade, IF, IHC-F, FC, WB | BE0101 | BP0101 |
| CTLA-4 (CD152) | in vivo CTLA-4 neutralization, WB | BE0164 | BP0164 |
| in vivo and in vitro CTLA-4 neutralization | BE0131 | BP0131 | |
| CD4 | in vivo CD4+ T cell depletion, FC | BE0003-1 | BP0003-1 |
| Ly6G | in vivo neutrophil depletion, in vivo MDSC depletion, IF, IHC-P, IHC-F, FC | BE0075-1 | BP0075-1 |
| in vivo depletion of Gr-1+ myeloid cells, FC | BE0075 | BP0075 | |
| CD8α | in vivo CD8+T cell depletion | BE0061 BE0117 |
BP0061 BP0117 |
| in vivo CD8+ T cell depletion, IF, FC | BE0004-1 | BP0004-1 | |
| OX40 (CD134) | in vivo and in vitro OX40 activation | BE0031 | |
| CSF1R (CD115) | in vivo macrophage/monocyte depletion, in vitro CSF-R1 neutralization, FC | BE0213 | |
| CD40 | in vivoCD40 activation, in vitro B cell stimulation, in vitro DC stimulation | BE0016-2 | BP0016-2 |
| IFNγ | in vivo and in vitro IFNγ neutralization, ELISPOT, FC | BE0055 | BP0055 |
| GITR | in vivo GITR stimulation | BE0063 | |
| CD154 (CD40L) | in vivo and in vitro blocking of CD40/CD40L signaling | BE0017-1 | BP0017-1 |
| NK1.1 | in vivo NK cell depletion, FC | BE0036 | BP0036 |
| TGF-β | in vivo TGFβ neutralization, in vitro TGFβ neutralization | BE0057 | BP0057 |
▶ 畅销同型对照抗体
| 同型对照 | InVivoMab | InVivoPlus |
| 目录号 | 目录号 | |
| InVivoMAb rat IgG2a isotype control, anti-trinitrophenol | BE0089 | BP0089 |
| InVivoMAb rat IgG2b isotype control, anti-keyhole limpet hemocyanin | BE0090 | BP0090 |
| InVivoMAb mouse IgG1 isotype control, unknown specificity | BE0083 | BP0083 |
| InVivoMAb rat IgG1 isotype control, anti-horseradish peroxidase | BE0088 | BP0088 |
| InVivoMAb mouse IgG2a isotype control, unknown specificity | BE0085 | BP0085 |
| InVivoMAb mouse IgG2b isotype control, unknown specificity | BE0086 | BP0086 |
| InVivoMAb polyclonal Armenian hamster IgG | BE0091 | BP0091 |
▶ 细胞耗竭（Depletion）抗体
|
细胞类型 |
抗体指标 |
克隆号 |
产品货号 |
同型对照 |
|
B细胞 |
B220 |
RA3.3A1/6.1 |
BE0067 |
BE0094 |
|
CD19 |
1D3 |
BE0150 |
BE0089 |
|
|
CD20 |
MB20-11 |
BE0356 BP0356 |
BE0366 BP0366 |
|
|
T细胞
|
CD3ε |
145-2C11 |
BE0001-1 BP0001-1 |
BE0091 BP0091 |
|
CD3ε |
145-2C11 f(ab')2 Fragments |
BE0001-1FAB |
BE0091-FAB |
|
|
Thy1.2 (CD90.2) |
30H12 |
BE006 BP0066 |
BE0090 BP0090 |
|
|
Thy1.1 (CD90.1) |
19E12 |
BE0214 |
BE0085 |
|
|
Thy1 (CD90) |
M5/49.4.1 |
BE0076 |
BE0089 |
|
|
TCRβ |
H57-597 |
BE0102 |
BE0091 |
|
|
CD4+T细胞 |
CD4 |
GK1.5 |
BE0003-1 BP0003-1 |
BE0090 BP0090 |
|
CD4 |
YTS 191 |
BE0119 |
BE0090 |
|
|
CD8+T细胞
|
CD8α |
2.43 |
BE0061 BP0061 |
BE0090 BP0090 |
|
CD8α |
53-6.7 |
BE0004-1 BP0004-1 |
BE0089 BP0089 |
|
|
CD8α |
YTS 169.4 |
BE0117 BP0117 |
BE0090 BP0090 |
|
|
CD8 (Lyt 2.1) |
116-13.1 |
BE0118 |
BE0085 |
|
|
CD8β |
53-5.8 |
BE0223 |
BE0088 |
|
|
Treg细胞
|
CD25 (IL-2Rα) |
PC-61.5.3 |
BE0012 BP0012 |
BE0088 BP0088 |
|
γδ T细胞
|
Vγ2 TCR |
UC3-10A6 |
BE0168 |
BE0091 |
|
ILCs
|
Thy1.2 (CD90.2) |
30H12 |
BE0066 BP0066 |
BE0090 BP0090 |
|
NK细胞
|
NK1.1 |
PK136 |
BE0036 BP0036 |
BE0085 BP0085 |
|
CD122 (IL-2Rβ) |
TM-beta 1 |
BE0298 |
BE0090 |
|
|
嗜中性粒细胞 |
Ly6G |
1A8 |
BE0075-1 BP0075-1 |
BE0089 BP0089 |
|
Ly6G/Ly6C (Gr-1) |
RB6-8C5 |
BE0075 BP0075 |
BE0090 BP0090 |
|
|
Ly6G/Ly6C |
NIMP-R14 |
BE0320 |
BE0090 |
|
|
嗜酸粒细胞
|
IL-5 |
TRFK5 |
BE0198 |
BE0088 |
|
CCR3 (CD193) |
6S2-19-4 |
BE0316 |
BE0090 |
|
|
巨噬细胞 |
CSF1R (CD115) |
AFS98 |
BE0213 BP0213 |
BE0089 BP0089 |
|
F4/80 |
CI:A3-1 |
BE0206 |
BE0090 |
|
|
Ly6C |
Monts 1 |
BE0203 |
BE0089 |
|
|
单核细胞 |
Ly6G/Ly6C (Gr-1) |
RB6-8C5 |
BE0075 BP0075 |
BE0090 BP0090 |
|
CSF1R |
AFS98 |
BE0213 BP0213 |
BE0089 BP0089 |
|
|
F4/80 |
CI:A3-1 |
BE0206 |
BE0090 |
|
|
浆细胞样树突细胞 |
CD317 (PDCA-1) |
927 |
BE0311 |
BE0090 |
|
肥大细胞
|
c-Kit |
ACK2 |
BE0293 |
BE0090 |
更多产品详情请咨询 BioXCell 中国授权代理——欣博盛生物
全国服务热线: 4006-800-892 邮箱: market@neobioscience.com
深圳: 0755-26755892 北京: 010-88594029
广州：020-87615159 上海: 021-34613729
代理品牌网站: www.neobioscience.com
自主品牌网站: www.neobioscience.net